Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 3.260
+0.040 (1.24%)
Sep 15, 2026, 5:17 PM AEST
Artrya Revenue
In the fiscal year ending June 30, 2026, Artrya had annual revenue of 28.00K AUD. Artrya had revenue of 14.00K in the half year ending June 30, 2026.
Revenue
28.00K
Revenue Growth
n/a
P/S Ratio
18,973.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
531.26M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 28.00K | - | - |
| Jun 30, 2025 | 28.00K | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 87.98M |
| Doctor Care Anywhere Group | 75.18M |
| Alcidion Group | 51.64M |
| Mach7 Technologies | 29.70M |
| Oneview Healthcare | 18.40M |
| Pharmx Technologies | 7.62M |
| Emyria | 4.05M |
| Singular Health Group | 1.90M |
Artrya News
- 4 weeks ago - Artrya Annual report: H2 2026 - Filings
- 6 months ago - Artrya Quarterly report: H1 2026 - Filings
- 7 months ago - Artrya Earnings Call Transcript: Q2 2026 - Transcripts
- 7 months ago - Artrya Earnings release: Q2 2026 - Filings
- 9 months ago - Artrya Transcript: Bell Potter Healthcare Conference 2025 - Transcripts
- 10 months ago - Artrya Transcript: AGM 2025 - Transcripts
- 10 months ago - Artrya Slides: FY 2025 - Filings
- 10 months ago - Artrya Earnings Call Transcript: Q1 2026 - Transcripts